Alaunos Therapeutics, Inc. (TCRT)
NASDAQ·Healthcare·Biotechnology
$2.54
-5.93%
Mkt Cap $8.15M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 31, 2026 | $3.00K | $3.00K | +0.00% | -$3.69 | -$0.40 | +89.15% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$4.90 | -$0.55 | +88.78% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$5.33 | -$0.63 | +88.19% | — | — |
| Q2 2025 May 15, 2025 | — | $2.00K | — | -$6.44 | -$0.67 | +89.60% | — | — |
| Q1 2025 Mar 31, 2025 | — | $4.00K | — | -$4.50 | -$0.46 | +89.78% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$4.50 | -$0.70 | +84.44% | — | — |
| Q3 2024 Aug 14, 2024 | — | $4.00K | — | -$4.50 | -$0.71 | +84.22% | — | — |
| Q2 2024 May 15, 2024 | — | $1.00K | — | -$4.50 | -$1.10 | +75.56% | — | — |
| Q2 2024 Apr 2, 2024 | — | $1.00K | — | -$0.45 | -$0.49 | -8.89% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$4.50 | -$6.00 | -33.33% | — | — |
| Q3 2023 Aug 14, 2023 | — | $4.00K | — | -$6.00 | -$6.00 | +0.00% | — | — |
| Q2 2023 May 10, 2023 | — | — | — | -$6.00 | -$6.00 | +0.00% | — | — |
| Q1 2023 Mar 7, 2023 | — | $11.00K | — | -$13.49 | -$6.00 | +55.52% | — | — |
| Q4 2022 Nov 14, 2022 | — | $2.91M | — | -$17.99 | -$6.00 | +66.65% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$16.49 | -$7.50 | +54.52% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$13.49 | -$7.50 | +44.40% | — | — |
| Q1 2022 Mar 30, 2022 | — | — | — | -$13.49 | -$7.50 | +44.40% | — | — |
| Q4 2021 Nov 8, 2021 | — | $398.00K | — | -$0.13 | -$0.11 | +15.38% | — | — |
| Q3 2021 Aug 13, 2021 | — | — | — | -$0.12 | -$0.11 | +8.33% | — | — |
| Q2 2021 May 6, 2021 | — | — | — | -$0.10 | -$0.10 | +0.00% | — | — |